Roche · 5 hours ago
2026 Summer Intern - Business Manager - ECD Chief of Staff Office
Roche is a leading biotechnology company, and they are seeking a 2026 Summer Intern for the Business Manager role in the ECD Chief of Staff Office. This internship will provide experience in strategic partnerships, business planning, and execution, working closely with the ECD Chief of Staff and other Business Managers.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Data analysis, organization & presentation
Project coordination and management
Evaluating best practices and streamlining standard work processes
Contributing to meetings and events (e.g. Town Halls, functional team meetings)
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student - undergraduate students with 2–3 years of coursework in business, operations, or a STEM-related field)
Strong written and verbal communication skills
Agile mindset to adapt to changing work demands
Passion for learning with a willingness to adopt new tools/processes
Enthusiasm for sharing colleagues' accomplishments
Proficiency with Google Suite products
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Actively contributing to a fun and creative team culture
Team-oriented and collaborative, with the ability to work independently
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase